LOADING
Comparing NVIDIA Corporation (NVDA) and Eli Lilly and Company (LLY) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | NVDA | LLY |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | -- | $837.4B |
| P/E Ratio | -- | 40.8 |
| Forward P/E | -- | 28.0 |
| PEG Ratio | -- | 1.03 |
| EPS | -- | $22.92 |
| Revenue Growth (YoY) | -- | 42.6% |
| Profit Margin | -- | 31.7% |
| Return on Equity | -- | 101.2% |
| Dividend Yield | -- | 0.63% |
| Beta | -- | 0.43 |
| 52-Week High | -- | $1,132.06 |
| 52-Week Low | -- | $620.46 |
| Volume | -- | -- |